Feb 23, 2025, 5:42 PM
Feb 20, 2025, 10:53 AM

Dolphins Cancer Challenge raises over $14 million for research

Highlights
  • Thousands gathered in Miami for the annual Dolphins Cancer Challenge on February 22, 2025.
  • The event raised over $14 million for cancer research and saw participation from a record 7,000 individuals.
  • This fundraising effort highlights the ongoing commitment to fight cancer and advance research initiatives.
Story

In Miami, USA, the Dolphins Cancer Challenge (DCC) took place on February 22, 2025, with thousands of participants engaged in walking, running, and cycling to raise funds for cancer research. The event started early in the morning with packet pickup at 4:30 a.m. and concluded around 4 p.m. with participants crossing the finish line. The DCC, known as the No. 1 fundraiser in the NFL, featured five routes named in honor of Miami Dolphins players from the Pro Football Hall of Fame, with several routes accommodating various participant levels and experiences. A record participation of over 7,000 individuals was reported this year, all united by a personal connection to the cause. Many participants have either battled cancer themselves or rode in support of loved ones affected by the disease. Through this collective effort, the DCC has raised over $75 million since its inception in 2010 and is projected to approach the $90 million mark with the latest contributions. The funds raised during this event go directly to Sylvester Comprehensive Cancer Center, associated with UHealth at the University of Miami Health System. The significance of the contributions was highlighted by personal stories shared by participants, illustrating the profound impact that the research and care provided at Sylvester have on the lives of many fighting cancer. Leaders from the Miami Dolphins organization expressed their hope for a future where fundraising is directed towards other causes rather than cancer, emphasizing the importance of early detection and continuous support for those affected by the disease.

Opinions

You've reached the end